Effect of Daily Fiber Intake Among Cirrhotic Patients With and Without Portosystemic Shunts

Background: A diet rich in fiber, especially soluble fiber, causes cholestatic liver damage and fibrosis in animal models with intestinal dysbiosis, high serum bile acid concentrations, and congenital portosystemic shunts (PSs), but no data on patients with cirrhosis (CIRs) are available. Objectives...

Full description

Saved in:
Bibliographic Details
Main Authors: Simona Parisse, Sara Carnevale, Elio Damato, Flaminia Ferri, Monica Mischitelli, Mario Corona, Pierleone Lucatelli, Alfredo Cantafora, Adriano De Santis, Domenico Alvaro, Maurizio Muscaritoli, Stefano Ginanni Corradini
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Current Developments in Nutrition
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2475299124024612
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590914749464576
author Simona Parisse
Sara Carnevale
Elio Damato
Flaminia Ferri
Monica Mischitelli
Mario Corona
Pierleone Lucatelli
Alfredo Cantafora
Adriano De Santis
Domenico Alvaro
Maurizio Muscaritoli
Stefano Ginanni Corradini
author_facet Simona Parisse
Sara Carnevale
Elio Damato
Flaminia Ferri
Monica Mischitelli
Mario Corona
Pierleone Lucatelli
Alfredo Cantafora
Adriano De Santis
Domenico Alvaro
Maurizio Muscaritoli
Stefano Ginanni Corradini
author_sort Simona Parisse
collection DOAJ
description Background: A diet rich in fiber, especially soluble fiber, causes cholestatic liver damage and fibrosis in animal models with intestinal dysbiosis, high serum bile acid concentrations, and congenital portosystemic shunts (PSs), but no data on patients with cirrhosis (CIRs) are available. Objectives: To investigate whether dietary fiber consumption was associated with clinical outcomes of CIRs and whether their effect differed according to the presence of PSs. Methods: Daily soluble and insoluble fiber intake was extrapolated from 3-d food diaries in 25 patients with chronic hepatitis (CH) and 80 CIRs outpatient liver transplant candidates abstinent from alcohol and nonviremic for ≥6 mo. In CIRs, the presence of PSs was verified by computed tomography, and the model for end-stage liver disease (MELD) score was calculated at enrollment and after 6 mo. Results: PSs were present in 48 (60%) CIRs. The MELD score after 6 mo, compared with enrollment, had improved in 19 and 10 CIRs with and without PSs, respectively. By adjusting for confounders in logistic regression models we found that improvement in MELD over time was inversely associated with insoluble fiber consumption expressed in milligrams per kilogram (mg/kg) body weight in CIRs without PSs [odds ratio (OR): 0.968; 95% confidence interval (CI): 0.939, 0.997; P = 0.005] but with soluble fiber consumption in CIRs with PSs [OR: 0.946; 95% CI: 0.912, 0.982; P = 0.001]. In CIRs with PSs, soluble fiber consumption was inversely associated with normal serum alkaline phosphatase values at enrollment [OR: 0.964; 95% CI: 0.963, 0.993; P = 0.010]. CHs with normal serum alanine transaminase consumed significantly more soluble fiber (p=0.015) than those with abnormal alanine transaminase. Conclusions: The clinical impact of dietary fiber changes from beneficial to harmful as the stage of chronic liver disease progresses. In particular, in the advanced cirrhosis stage with PSs, soluble fiber intake appears to significantly influence disease progression and should be kept low.
format Article
id doaj-art-cbe36f558cf2462f9b43965d1d178393
institution Kabale University
issn 2475-2991
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Current Developments in Nutrition
spelling doaj-art-cbe36f558cf2462f9b43965d1d1783932025-01-23T05:27:33ZengElsevierCurrent Developments in Nutrition2475-29912025-01-0191104527Effect of Daily Fiber Intake Among Cirrhotic Patients With and Without Portosystemic ShuntsSimona Parisse0Sara Carnevale1Elio Damato2Flaminia Ferri3Monica Mischitelli4Mario Corona5Pierleone Lucatelli6Alfredo Cantafora7Adriano De Santis8Domenico Alvaro9Maurizio Muscaritoli10Stefano Ginanni Corradini11Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, ItalyBelcolle Hospital, Viterbo, ItalyDepartment of Radiological, Oncological and Anatomopathological Sciences, Sapienza University of Rome, Rome, ItalyDepartment of Translational and Precision Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Translational and Precision Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Radiological, Oncological and Anatomopathological Sciences, Sapienza University of Rome, Rome, ItalyDepartment of Radiological, Oncological and Anatomopathological Sciences, Sapienza University of Rome, Rome, ItalyDepartment of Translational and Precision Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Translational and Precision Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Translational and Precision Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Translational and Precision Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy; Corresponding author.Background: A diet rich in fiber, especially soluble fiber, causes cholestatic liver damage and fibrosis in animal models with intestinal dysbiosis, high serum bile acid concentrations, and congenital portosystemic shunts (PSs), but no data on patients with cirrhosis (CIRs) are available. Objectives: To investigate whether dietary fiber consumption was associated with clinical outcomes of CIRs and whether their effect differed according to the presence of PSs. Methods: Daily soluble and insoluble fiber intake was extrapolated from 3-d food diaries in 25 patients with chronic hepatitis (CH) and 80 CIRs outpatient liver transplant candidates abstinent from alcohol and nonviremic for ≥6 mo. In CIRs, the presence of PSs was verified by computed tomography, and the model for end-stage liver disease (MELD) score was calculated at enrollment and after 6 mo. Results: PSs were present in 48 (60%) CIRs. The MELD score after 6 mo, compared with enrollment, had improved in 19 and 10 CIRs with and without PSs, respectively. By adjusting for confounders in logistic regression models we found that improvement in MELD over time was inversely associated with insoluble fiber consumption expressed in milligrams per kilogram (mg/kg) body weight in CIRs without PSs [odds ratio (OR): 0.968; 95% confidence interval (CI): 0.939, 0.997; P = 0.005] but with soluble fiber consumption in CIRs with PSs [OR: 0.946; 95% CI: 0.912, 0.982; P = 0.001]. In CIRs with PSs, soluble fiber consumption was inversely associated with normal serum alkaline phosphatase values at enrollment [OR: 0.964; 95% CI: 0.963, 0.993; P = 0.010]. CHs with normal serum alanine transaminase consumed significantly more soluble fiber (p=0.015) than those with abnormal alanine transaminase. Conclusions: The clinical impact of dietary fiber changes from beneficial to harmful as the stage of chronic liver disease progresses. In particular, in the advanced cirrhosis stage with PSs, soluble fiber intake appears to significantly influence disease progression and should be kept low.http://www.sciencedirect.com/science/article/pii/S2475299124024612cirrhosiscirrhotic dietliver transplantationMELDliver damage
spellingShingle Simona Parisse
Sara Carnevale
Elio Damato
Flaminia Ferri
Monica Mischitelli
Mario Corona
Pierleone Lucatelli
Alfredo Cantafora
Adriano De Santis
Domenico Alvaro
Maurizio Muscaritoli
Stefano Ginanni Corradini
Effect of Daily Fiber Intake Among Cirrhotic Patients With and Without Portosystemic Shunts
Current Developments in Nutrition
cirrhosis
cirrhotic diet
liver transplantation
MELD
liver damage
title Effect of Daily Fiber Intake Among Cirrhotic Patients With and Without Portosystemic Shunts
title_full Effect of Daily Fiber Intake Among Cirrhotic Patients With and Without Portosystemic Shunts
title_fullStr Effect of Daily Fiber Intake Among Cirrhotic Patients With and Without Portosystemic Shunts
title_full_unstemmed Effect of Daily Fiber Intake Among Cirrhotic Patients With and Without Portosystemic Shunts
title_short Effect of Daily Fiber Intake Among Cirrhotic Patients With and Without Portosystemic Shunts
title_sort effect of daily fiber intake among cirrhotic patients with and without portosystemic shunts
topic cirrhosis
cirrhotic diet
liver transplantation
MELD
liver damage
url http://www.sciencedirect.com/science/article/pii/S2475299124024612
work_keys_str_mv AT simonaparisse effectofdailyfiberintakeamongcirrhoticpatientswithandwithoutportosystemicshunts
AT saracarnevale effectofdailyfiberintakeamongcirrhoticpatientswithandwithoutportosystemicshunts
AT eliodamato effectofdailyfiberintakeamongcirrhoticpatientswithandwithoutportosystemicshunts
AT flaminiaferri effectofdailyfiberintakeamongcirrhoticpatientswithandwithoutportosystemicshunts
AT monicamischitelli effectofdailyfiberintakeamongcirrhoticpatientswithandwithoutportosystemicshunts
AT mariocorona effectofdailyfiberintakeamongcirrhoticpatientswithandwithoutportosystemicshunts
AT pierleonelucatelli effectofdailyfiberintakeamongcirrhoticpatientswithandwithoutportosystemicshunts
AT alfredocantafora effectofdailyfiberintakeamongcirrhoticpatientswithandwithoutportosystemicshunts
AT adrianodesantis effectofdailyfiberintakeamongcirrhoticpatientswithandwithoutportosystemicshunts
AT domenicoalvaro effectofdailyfiberintakeamongcirrhoticpatientswithandwithoutportosystemicshunts
AT mauriziomuscaritoli effectofdailyfiberintakeamongcirrhoticpatientswithandwithoutportosystemicshunts
AT stefanoginannicorradini effectofdailyfiberintakeamongcirrhoticpatientswithandwithoutportosystemicshunts